Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01 and SMC Extension Study
NCT04319380Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2020
- Primary completion
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of RTS,S in Plasmodium falciparum malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Incidence of Clinical Episodes of Malaria at 24 months. Started Apr 2020; status: completed.
02
Drugs
RTS,S
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04319380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319380.